Nov 29, 2022 / 06:00PM GMT
Umer Raffat - Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Thank you guys for joining us. We have tons to review today. Thank you, Andy and Bill for joining us. And it's not Bill Anderson, it's Bill Grossman, but -- I'm clearly not getting enough sleep. But let me turn it over to you first, Andy and Bill to kick things off, and we'll jump right in.
Andrew D. Dickinson - Gilead Sciences, Inc. - Executive VP & CFO
I'll start on our side. Thanks for having us, Umer. It's always good to catch up, and I appreciate the opportunity to join the conference. Maybe and really, would it be helpful just to start with kind of setting the stage for 2022 and where we are and where we see the business going, or do you want to jump right into some of the (inaudible) questions?
Umer Raffat - Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
No, no, no, why don't you kick it off and I'll jump right in then.
Gilead Sciences Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers